23G微创玻璃体切割术治疗恶性青光眼的疗效分析

Curative effect analysis of 23 G micro-invasive vitrectomy on treatment of malignant glaucoma

目的探讨23G微创玻璃体切割术治疗恶性青光眼的疗效。方法回顾性分析我院2014年1月—2017年1月收治70的例恶性青光眼患者,根据病史不同分为2组,A组为继发性青光眼患者,B组为原发性患者,均在接受不同手术之治疗基础上加用23G微创玻璃体切割术。比较2组患者手术前后眼压情况,术后4个月视力情况,不良事件发生率。结果治疗前2组患者眼压比较无统计学差异(P>0.05),治疗第1天、第30天、第60天B组患者眼压均低于A组(P<0.05)。2组患者术后4个月视力情况比较有统计学差异(P<0.05)。2组患者不良事件发生率比较无统计学差异(P>0.05)。结论 23G微创玻璃体切割术治疗恶性青光眼能够显著改善患者视力水平且安全性较好,对原发性恶性青光眼效果尤佳,可推荐使用。

Objective To investigate the curative effect of 23 G micro-invasive vitrectomy on treatment of malignant glaucoma. Methods 70 cases with malignant glaucoma in our hospital from January 2014 to January 2017 were selected and divided into group A（patients with secondary glaucoma） and group B（patients with primary glaucoma）,they were all given 23 G micro-invasive vitrectomy on basis of different treatment. Intraocular tension condition before and after surgery,information acuity of vision after 4 months,adverse events occurrence of the two groups were compared. Results Before treatment,the difference of intraocular tension between the two groups had no statistic significance（P〈0.05）,after treatment of 1 D,30 D and 60 D,the intraocular tension of group B was lower than that of group A（P〈0.05）.After 4 months,the difference was statistic significant（P〈0.05）.The difference of adverse event rate between group A and group B was not statistic significant（P〈0.05）.Conclusion 23 G micro-invasive vitrectomy has better curative effect on treatment of primary/secondary malignantglaucoma,it can significantly improve vision level and is worthy of wide application.